Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
La Nouvelle Presse Medicale
|
February 8, 1975
[Catheterization in orificial aortic stenosis]
H Geschwind, A Nitenberg, P Grivas
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Cancer vaccines at the age of immune checkpoint inhibitors: reasonable approach as combination therapy in advanced urothelial carcinoma?
P Grivas, V S Koshkin, S K Pal
British Heart Journal
|
July 1, 1973
Use of atropine for higher right atrial pacing rates. 'Maximal' pacing for diagnosis of coronary artery disease
D V Cokkinos, S Katsaros, P Grivas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 5, 2018
Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer
I Sokolov, M E Dokukin, V Kalaparthi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2020
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
J Haanen, M S Ernstoff, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance
P C Barata, V S Koshkin, P Funchain, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
ESMO Open
|
June 12, 2026
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus
J B Aragon-Ching, S Gupta, P Grivas, et al.
ESMO Open
|
November 19, 2025
Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence study
B A Maiorano, A Cigliola, V Tateo, et al.
ESMO Open
|
July 7, 2023
Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia
L Castelo-Branco, R Lee, M Brandão, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
La Nouvelle Presse Medicale
|
February 8, 1975
[Catheterization in orificial aortic stenosis]
H Geschwind, A Nitenberg, P Grivas
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Cancer vaccines at the age of immune checkpoint inhibitors: reasonable approach as combination therapy in advanced urothelial carcinoma?
P Grivas, V S Koshkin, S K Pal
British Heart Journal
|
July 1, 1973
Use of atropine for higher right atrial pacing rates. 'Maximal' pacing for diagnosis of coronary artery disease
D V Cokkinos, S Katsaros, P Grivas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 5, 2018
Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer
I Sokolov, M E Dokukin, V Kalaparthi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2020
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
J Haanen, M S Ernstoff, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance
P C Barata, V S Koshkin, P Funchain, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
ESMO Open
|
June 12, 2026
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus
J B Aragon-Ching, S Gupta, P Grivas, et al.
ESMO Open
|
November 19, 2025
Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence study
B A Maiorano, A Cigliola, V Tateo, et al.
ESMO Open
|
July 7, 2023
Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia
L Castelo-Branco, R Lee, M Brandão, et al.
Page
of 3